Prelude Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,785
Closed -$900K 981
2025
Q1
$900K Buy
6,785
+3,872
+133% +$493K 0.07% 338
2024
Q4
$329K Buy
+2,913
New +$337K 0.02% 761
2023
Q2
Sell
-4,671
Closed -$473K 1090
2023
Q1
$473K Buy
4,671
+1,492
+47% +$158K 0.03% 480
2022
Q4
$349K Sell
3,179
-1,815
-36% -$188K 0.02% 724
2022
Q3
$483K Sell
4,994
-21,381
-81% -$2.28M 0.02% 672
2022
Q2
$2.87M Buy
+26,375
New +$3M 0.08% 195
2021
Q3
Sell
-3,727
Closed -$458K 1677
2021
Q2
$432K Sell
3,727
-1,142
-23% -$133K 0.01% 1031
2021
Q1
$584K Buy
4,869
+1,869
+62% +$221K 0.02% 823
2020
Q4
$328K Buy
+3,000
New +$326K 0.01% 879
2020
Q3
Sell
-15,470
Closed -$1.41M 1760
2020
Q2
$1.41M Buy
15,470
+7,791
+101% +$704K 0.08% 234
2020
Q1
$606K Sell
7,679
-4,755
-38% -$397K 0.04% 289
2019
Q4
$1.08M Buy
12,434
+10,504
+544% +$880K 0.04% 366
2019
Q3
$161K Sell
1,930
-28,698
-94% -$2.44M 0.01% 812
2019
Q2
$2.58M Sell
30,628
-2,317
-7% -$182K 0.13% 144
2019
Q1
$2.63M Buy
32,945
+5,463
+20% +$406K 0.15% 134
2018
Q4
$1.99M Buy
27,482
+5,395
+24% +$379K 0.13% 172
2018
Q3
$1.62M Buy
22,087
+2,647
+14% +$174K 0.09% 245
2018
Q2
$1.19M Sell
19,440
-1,690
-8% -$102K 0.08% 289
2018
Q1
$1.27M Buy
21,130
+1,787
+9% +$108K 0.09% 222
2017
Q4
$1.1M Buy
19,343
+440
+2% +$24.4K 0.09% 239
2017
Q3
$1.01M Buy
+18,903
New +$948K 0.09% 240
2017
Q2
Sell
-717
Closed -$32K 1567
2017
Q1
$32K Buy
+717
New +$31K ﹤0.01% 1166
2016
Q2
Sell
-1,454
Closed -$61K 1547
2016
Q1
$61K Buy
+1,454
New +$57.6K 0.01% 923
2015
Q3
Sell
-941
Closed -$46K 1444
2015
Q2
$46K Sell
941
-175
-16% -$8.4K 0.01% 1171
2015
Q1
$52K Buy
+1,116
New +$51.3K 0.01% 1255
2014
Q4
Sell
-1,292
Closed -$54K 1863
2014
Q3
$54K Buy
1,292
+442
+52% +$18.7K 0.01% 1364
2014
Q2
$35K Sell
850
-1,064
-56% -$41.8K ﹤0.01% 1583
2014
Q1
$74K Buy
+1,914
New +$73.8K 0.01% 1146

Other funds holding ABT

Prelude Capital Management's ABT Position: Q2 2025 in Review

Prelude Capital Management sold out of Abbott (ABT) in Q2 2025, closing a stake of 6,785 shares — an estimated $900K sold.

Prelude Capital Management first reported a position in ABT in Q1 2014 and held it in 28 quarters. The position peaked at $2.87M in Q2 2022. 3,184 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

  • Prelude Capital Management reported no remaining Abbott position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 6,785 Abbott shares in Q2 2025, an estimated $900K.
  • Prelude Capital Management first reported a position in Abbott in Q1 2014 and held it in 28 quarters.
  • Prelude Capital Management's Abbott position peaked at $2.87M in Q2 2022.
  • 3,184 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.